MRVI Crosses Above Average Analyst Target
In recent trading, shares of Maravai LifeSciences Holdings Inc (Symbol: MRVI) have crossed above the average analyst 12-month target price of $7.42, changing hands for $7.65/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: d
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.